Autophagy is the predominant process induced by arsenite in human lymphoblastoid cell lines

Toxicology and Applied Pharmacology

Volumn 244, Issue 3, 2010, Pages 366-373

  Bolt, Alicia M ^a   Byrd, Randi M ^a   Klimecki, Walter T ^a  

^a UNIVERSITY OF ARIZONA   (United States)

Author keywords

Autophagy; Cytotoxicity; Lymphoblastoid; Sodium arsenite

Indexed keywords

ARSENIC TRIOXIDE; CASPASE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PHOSPHATIDYLSERINE; ARSENITE SODIUM; ARSENOUS ACID DERIVATIVE; CYTOTOXIN; SODIUM DERIVATIVE;

APOPTOSIS; ARTICLE; AUTOPHAGY; CELL LINE; CELL STRESS; CONTROLLED STUDY; CYTOTOXICITY; ELECTRON MICROSCOPY; ENZYME INHIBITION; FLUORESCENCE MICROSCOPY; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IN VITRO STUDY; LYMPHOBLASTOID CELL; WESTERN BLOTTING; BIOLOGICAL MODEL; DRUG EFFECT; FEMALE; LYMPHOCYTE; POLLUTANT; TOXICITY TESTING; ULTRASTRUCTURE;

APOPTOSIS; ARSENITES; AUTOPHAGY; CELL LINE; CYTOTOXINS; ENVIRONMENTAL POLLUTANTS; FEMALE; HUMANS; LYMPHOCYTES; MODELS, BIOLOGICAL; SODIUM COMPOUNDS; TOXICITY TESTS;

EID: 77950488550     PISSN: 0041008X     EISSN: 10960333     Source Type: Journal    
DOI: 10.1016/j.taap.2010.01.019     Document Type: Article

References (42)

1. Aoki H., Kondo Y., Aldape K., Yamamoto A., Iwado E., Yokoyama T., Hollingsworth E.F., Kobayashi R., Hess K., Shinojima N., Shingu T., Tamada Y., Zhang L., Conrad C., Bogler O., Mills G., Sawaya R., Kondo S. Monitoring autophagy in glioblastoma with antibody against isoform B of human microtubule-associated protein 1 light chain 3. Autophagy 2008, 4:467-475.
2. Apel A., Zentgraf H., Buchler M.W., Herr I. Autophagy-a double-edged sword in oncology. Int. J. Cancer 2009, 125:991-995.
3. Barchowsky A., Dudek E.J., Treadwell M.D., Wetterhahn K.E. Arsenic induces oxidant stress and NF-kappa B activation in cultured aortic endothelial cells. Free Radic. Biol. Med. 1996, 21:783-790.
4. Calle E., Berciano M.T., et al. Activation of the autophagy, c-FOS and ubiquitin expression, and nucleolar alterations in Schwann cells precede demyelination in tellurium-induced neuropathy. Acta Neuropathol. 1999, 97(2):143-155.
5. Charoensuk V., Gati W.P., Weinfeld M., Le X.C. Differential cytotoxic effects of arsenic compounds in human acute promyelocytic leukemia cells. Toxicol. Appl. Pharmacol. 2009, 26:1681-1692.
6. Concannon C.G., Koehler B.F., et al. Apoptosis induced by proteasome inhibition in cancer cells: predominant role of the p53/PUMA pathway. Oncogene 2007, 26(12):1681-1692.
7. Deretic V., Levine B. Autophagy, immunity, and microbial adaptations. Cell Host Microbe 2009, 5:527-549.
8. Glienke W., Chow K.U., Bauer N., Bergmann L. Down-regulation of wt1 expression in leukemia cell lines as part of apoptotic effect in arsenic treatment using two compounds. Leuk. Lymphoma 2006, 47:1629-1638.
9. Gonsebatt M.E., Vega L., Herrera L.A., Montero R., Rojas E., Cebrian M.E., Ostrosky-Wegman P. Inorganic arsenic effects on human lymphocyte stimulation and proliferation. Mutat. Res. 1992, 283:91-95.
10. Guo H.R., Yu H.S., Hu H., Monson R.R. Arsenic in drinking water and skin cancers: cell-type specificity (Taiwan, ROC). Cancer Causes Control 2001, 12:909-916.
11. Hartley T., Brumell J., Volchuk A. Emerging roles for the ubiquitin-proteasome system and autophagy in pancreatic beta-cells. Am. J. Physiol. Endocrinol. Metab. 2009, 296:E1-E10.
12. Hartmann A., Speit G. Comparative investigations of the genotoxic effects of metals in the single cells gel (SCG) assay and the sister chromatid exchange (SCE) test. Environ. Mol. Mutagen. 1994, 23:299-305.
13. Huang Y.C., Hung W.C., Chen W.T., Yu H.S., Chai C.Y. Sodium arsenite-induced DAPK promoter hypermethylation and autophagy via ERK1/2 phosphorylation in human uroepithelial cells. Chem. Biol. Interact. 2009, 181:254-262.
14. Kroemer G., Levine B. Autophagic cell death: the story of a misnomer. Nat. Rev. Mol. Cell Biol. 2008, 9:1004-1010.
15. Lee J.A. Autophagy in neurodegeneration: two sides of the same coin. BMB Rep. 2009, 42:324-330.
16. Lee D.Y., Sugden B. The latent membrane protein 1 oncogene modifies B-cell physiology by regulating autophagy. Oncogene 2008, 27:2833-2842.
17. Marks M.S. Eating thyself toward the dark side. Pigment Cell Melanoma Res. 2009, 22:251-252.
18. Martinet W., De Meyer G.R. Autophagy in atherosclerosis. Curr. Atheroscler. Rep. 2008, 10:216-223.
19. Mukherjee S.C., Rahman M.M., Chowdhury U.K., Sengupta M.K., Lodh D., Chanda C.R., Saha K.C., Chakraborti D. Neuropathy in arsenic toxicity from groundwater arsenic contamination in West Bengal, India. J. Environ. Sci. Health A Tox. Hazard Subst. Environ. Eng. 2003, 38:165-183.
20. Pattingre S., Tassa A., Qu X., Garuti R., Liang X.H., Mizushima N., Packer M., Schneider M.D., Levine B. Bcl-2 antiapoptotic proteins inhibit Beclin 1-dependent autophagy. Cell 2005, 122:927-939.
21. Piatek K., Schwerdtle T., Hartwig A., Bal W. Monomethylarsonous acid destroys a tetrathiolate zinc finger much more efficiently than inorganic arsenite: mechanistic considerations and consequences for DNA repair inhibition. Chem. Res. Toxicol. 2008, 21:600-606.
22. Pulido M.D., Parrish A.R. Metal-induced apoptosis: mechanisms. Mutat. Res. 2003, 533:227-241.
23. Qian W., Liu J., Jin J., Ni W., Xu W. Arsenic trioxide induces not only apoptosis but also autophagic cell death in leukemia cell lines via up-regulation of Beclin-1. Leuk. Res. 2007, 31:329-339.
24. Rahman M.M., Ng J.C., Naidu R. Chronic exposure of arsenic via drinking water and its adverse health impacts on humans. Environ. Geochem. Health 2009, 31(Suppl. 1):189-200.
25. Ramadan D., Rancy P.C., Nagarkar R.P., Schneider J.P., Thorpe C. Arsenic(III) species inhibit oxidative protein folding in vitro. Biochemistry 2009, 48:424-432.
26. Raqib R., Ahmed S., Sultana R., Wagatsuma Y., Mondal D., Hoque A.M., Nermell B., Yunus M., Roy S., Persson L.A., Arifeen S.E., Moore S., Vahter M. Effects of in utero arsenic exposure on child immunity and morbidity in rural Bangladesh. Toxicol. Lett. 2009, 185:197-202.
27. Rouschop K.M., Wouters B.G. Regulation of autophagy through multiple independent hypoxic signaling pathways. Curr. Mol. Med. 2009, 9:417-424.
28. Rubinsztein D.C., Cuervo A.M., Ravikumar B., Sarkar S., Korolchuk V., Kaushik S., Klionsky D.J. In search of an "autophagomometer". Autophagy 2009, 5:585-589.
29. Salazar A.M., Ostrosky-Wegman P., Menendez D., Miranda E., Garcia-Carranca A., Rojas E. Induction of p53 protein expression by sodium arsenite. Mutat. Res. 1997, 381:259-265.
30. Simeonova P.P., Luster M.I. Mechanisms of arsenic carcinogenicity: genetic or epigenetic mechanisms. J. Environ. Pathol. Toxicol. Oncol. 2000, 19:281-286.
31. Simeonova P.P., Wang S., Toriuma W., Kommineni V., Matheson J., Unimye N., Kayama F., Harki D., Ding M., Vallyathan V., Luster M.I. Arsenic mediates cell proliferation and gene expression in the bladder epithelium: association with activating protein-1 transactivation. Cancer Res. 2000, 60:3445-3453.
32. Smith A.H., Marshall G., Yuan Y., Ferreccio C., Liaw J., von Ehrenstein O., Steinmaus C., Bates M.N., Selvin S. Increased mortality from lung cancer and bronchiectasis in young adults after exposure to arsenic in utero and in early childhood. Environ. Health Perspect. 2006, 114:1293-1296.
33. States J.C., Srivastava S., Chen Y., Barchowsky A. Arsenic and cardiovascular disease. Toxicol. Sci. 2009, 107:312-323.
34. Sturlan S., Baumgartner M., Roth E., Bachleitner-Hofmann T. Docosahexaenoic acid enhances arsenic trioxide-mediated apoptosis in arsenic trioxide-resistant HL-60 cells. Blood 2003, 101:4990-4997.
35. Szegezdi E., Macdonald D.C., Ni Chonghaile T., Gupta S., Samali A. Bcl-2 family on guard at the ER. Am. J. Physiol. 2009, 296:C941-C953.
36. Yamamoto A., Tagawa Y., Yoshimori T., Moriyama Y., Masaki R., Tashiro Y. Bafilomycin A1 prevents maturation of autophagic vacuoles by inhibiting fusion between autophagosomes and lysosomes in rat hepatoma cell line, H-4-II-E cells. Cell Struct. Funct. 1998, 23:33-42.
37. Yang Y.P., Liang Z.Q., Gao B., Jia Y.L., Qin Z.H. Dynamic effects of autophagy on arsenic trioxide-induced death of human leukemia cell line HL60 cells. Acta Pharmacol. Sin. 2008, 29:123-134.
38. Yorimitsu T., Klionsky D.J. Autophagy: molecular machinery for self-eating. Cell Death Differ. 2005, 12(Suppl. 2):1542-1552.
39. Yoshimori T., Yamamoto A., Moriyama Y., Futai M., Tashiro Y. Bafilomycin A1, a specific inhibitor of vacuolar-type H(+)-ATPase, inhibits acidification and protein degradation in lysosomes of cultured cells. J. Biol. Chem. 1991, 266:17707-17712.
40. Zhang X., Yang F., Shim J.Y., Kirk K.L., Anderson D.E., Chen X. Identification of arsenic-binding proteins in human breast cancer cells. Cancer Lett. 2007, 255:95-106.
41. Zhang Q.Y., Mao J.H., Liu P., Huang Q.H., Lu J., Xie Y.Y., Weng L., Zhang Y., Chen Q., Chen S.J., Chen Z. A systems biology understanding of the synergistic effects of arsenic sulfide and Imatinib in BCR/ABL-associated leukemia. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:3378-3383.
42. Zhu X.H., Shen Y.L., Jing Y.K., Cai X., Jia P.M., Huang Y., Tang W., Shi G.Y., Sun Y.P., Dai J., Wang Z.Y., Chen S.J., Zhang T.D., Waxman S., Chen Z., Chen G.Q. Apoptosis and growth inhibition in malignant lymphocytes after treatment with arsenic trioxide at clinically achievable concentrations. J. Natl. Cancer Inst. 1999, 91:772-778.